Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Japan

Observers Optimistic On Takeda Profits

October 2006 | Company Finance Alert

A report published in leading Japanese business newspaper Nihon Keizai claims that leading indigenous drugmaker Takeda's recurring profit could exceed JPY500bn (US$4.2bn) this financial year - more than expected. Diabetes drug Actos (pioglitazone) is expected to drive sales growth of some 5%. Takeda reported a 26.3% jump in revenues from the product to JPY243.8bn (US$2.2bn) last

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
India's Cadila Sets Up Tokyo Office

Companies / Japan Cadila Healthcare, part of India's third-largest drug manufacturing group, Zydus Cadila, is to market its generics and active pharmaceutical ingredients (APIs) in Japan. The company has recruited a former...
September 2006
GSK To Boost Japan Launches

Companies / Japan According to international reports, UK drug major GlaxoSmithKline (GSK) is to increase launches of new products in Japan, aiming to boost sales by 10% per year. With local revenues of JPY186.6bn (US$1.62bn)...
June 2006
Industry Slams Japan's Regulatory Reforms

Companies / Japan Stakeholders in Japan's drug industry have criticised the government's handling of its five-year industry plan. The strategy was first outlined in 2002, and a draft version of the new five-year plan...
June 2006
Takeda Boosts R&D Spend, Market Share

Companies / Japan Leading Japanese drugmaker Takeda is to invest US$1.8bn in research and development in fiscal year 2006/07, according to local reports. Other leading local firms are also expected to boost R&D budgets...
May 2006
Sanofi-Aventis Pledges Japan Expansion

Companies / Japan French drug major Sanofi-Aventis is to expand in Japan and make the market a 'priority' over the next few years. The announcement follows the company's decision to reassume exclusive local rights to...
April 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS